Peptide PilotPeptide Pilot

mg ↔ units

BPC-157 mg to units converter

Set your BPC-157 vial concentration once, then flip in either direction between milligrams and U-100 syringe units.

Download Peptide PilotiPhone · Free to download

mg

0.250

units

10.0

mL

0.100

Concentration: 2.50 mg/mL (assumes a U-100 insulin syringe).

BPC-157 is a peptide people use to speed up recovery from soft-tissue injuries — tendons, ligaments, muscle strains, and gut-lining irritation. In animal studies it consistently accelerated tendon and muscle healing versus saline controls, often by promoting new blood-vessel growth at the injury site. Human clinical data is limited, so most reports are anecdotal. This page covers reconstitution math, typical daily logging cadence, and common mistakes.

How the BPC-157 mg ↔ units converter works

This converter is a two-way bridge between dose mass (mg or mcg) and the unit count you actually draw on an insulin syringe. Once you set the BPC-157 concentration of your current vial, you can type any mg value and read the units back, or type any unit count and read the mg back. It is the same math as the dose calculator, but bidirectional, which matters when you are checking a dose someone else recorded in units against a protocol written in mg.

The formula in both directions: mg = mL × concentration mg/mL, and units = mL × 100 on a U-100 syringe. With a 2.5 mg/mL BPC-157 solution, 0.25 mg comes out to 10 units, and 10 units comes out to 0.25 mg. The converter handles the unit flip automatically so you never multiply or divide in your head while holding a syringe.

Concentration is the input that changes the answer most. A 5 mg vial diluted with 1 mL is twice as concentrated as the same vial diluted with 2 mL, which means the same dose draws half as many units. That is the single biggest source of converter confusion: a remembered unit count from an old vial does not transfer to a new vial reconstituted with different water volume.

Use the converter whenever a protocol or research note is written in one unit and your syringe is labeled in the other. It is also useful for sanity-checking that a planned titration step lands at a unit count you can read accurately on the syringe — under five units gets hard to read, over fifty starts crowding into the back third of a 1 mL syringe.

Why this matters for BPC-157

BPC-157 — short for Body Protection Compound 157 — is a synthetic peptide originally derived from a sequence found in human gastric juice. It is one of the most widely discussed peptides in the research market, primarily because of its long history in animal studies looking at tissue and connective-tissue contexts.

BPC-157 is supplied as a lyophilized powder in vials rated in milligrams of active peptide. Common vial sizes are 2 mg, 5 mg, and 10 mg. Because typical illustrative doses are well below 1 mg, the dose calculator on this page defaults to micrograms — using mg with a typed value like 0.25 makes decimal-place mistakes much more likely than typing 250 mcg.

Unlike the long-acting GLP-1 peptides on this site, BPC-157 is short-acting and is typically logged on a daily — sometimes twice-daily — cadence in most personal logs. That changes the vial duration math significantly: even a small vial covers many doses on a weekly basis.

BPC-157 mechanism in plain English

BPC-157 is studied for its possible effects in tissue and connective-tissue contexts. The mechanistic literature is still developing and there are no peptide-page-appropriate clinical claims to make beyond noting that it remains a topic of active research.

Anyone tracking BPC-157 in a personal log will benefit from pairing the dose history with whatever metric the protocol is targeting — joint comfort ratings, recovery notes, or general wellbeing tracking. As with every peptide, the trend across weeks is what is meaningful, not any single day.

Published research on the mechanisms of BPC-157 frequently centers on its interaction with angiogenesis, the process of forming new blood vessels. Specifically, studies have observed its influence on the Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) signaling pathway. In various research models, the peptide has been documented to modulate the activation of this key receptor. This interaction is often studied in conjunction with the nitric oxide (NO) system, as the VEGFR2 pathway and NO synthesis are closely linked. The scientific inquiry focuses on how BPC-157 might influence these cascades, providing a framework for observing its effects at a molecular level without making clinical claims.

Tracking BPC-157 unit counts

Daily peptides like BPC-157 are where logging discipline matters most: the cadence is high, the doses are small, and the easiest mistake is double-dosing or skipping after losing track of the day. A timestamped dose log removes that ambiguity entirely.

The daily administration cadence often documented for BPC-157 makes meticulous injection site rotation tracking particularly important. Repeated subcutaneous injections at the same anatomical location can lead to palpable changes in the underlying subcutaneous fat tissue, a condition known as lipohypertrophy. To properly monitor for such changes, a detailed site rotation log is invaluable. A simple and effective method is to mentally divide the abdomen into four quadrants (upper-right, lower-right, upper-left, lower-left) and rotate through them systematically. Other potential sites like the deltoids, thighs, and glutes can also be incorporated into the rotation. Accurately recording the date and location of every injection allows an individual to audit their protocol and correlate any observed skin or tissue irregularities with their administration history.

Common BPC-157 conversion mistakes

  • Typing a milligram value into the calculator with the toggle still set to micrograms — produces a unit count 1000x too high.
  • Forgetting whether the morning dose was already taken on a twice-daily protocol — almost always a logging gap, not a math problem.
  • Reading 250 mcg as 25 units regardless of vial concentration. The unit count depends on diluent volume.
  • Reusing the previous vial's unit count after switching to a new vial reconstituted with a different volume.
  • Letting reconstituted BPC-157 sit at room temperature on travel days when a small cooler would have kept it cold.
  • Not recording the injection site, which makes site-rotation patterns invisible weeks later.
  • Failing to document the administration route, since both oral and subcutaneous methods are explored in research literature, making the route a critical variable.
  • Neglecting to log a detailed site rotation schedule, which makes it difficult to monitor for lipohypertrophy that can be observed with daily injections.
  • Assuming BPC-157 and TB-500 follow the same logging cadence when tracked as a stack, which can lead to inaccurate and conflated records.

Frequently asked questions about BPC-157 mg ↔ units

Why does the BPC-157 calculator default to micrograms?
Because typical illustrative doses are well below 1 mg, and typing 250 mcg is much less error-prone than typing 0.25 mg. The mg-mcg toggle is still available if the protocol you are following is framed in milligrams.
How is BPC-157 reconstituted?
Add a measured volume of bacteriostatic water through the rubber stopper, then swirl — not shake — until the lyophilized powder fully dissolves. A 5 mg vial with 2 mL of BAC water gives a concentration of 2,500 mcg per mL.
How many units of BPC-157 are in 250 mcg?
On a 5 mg vial reconstituted with 2 mL of bacteriostatic water (2,500 mcg per mL), 250 mcg is exactly 10 units on a U-100 insulin syringe. On a 5 mg vial with 1 mL of BAC water, the same dose is 5 units.
Is BPC-157 dosed daily?
Daily and twice-daily protocols are both common in personal logs. The cadence makes consistent logging especially valuable, because the easiest mistake on a daily peptide is losing track of whether a dose has already been taken.
How long does a 5 mg BPC-157 vial last?
At a 250 mcg daily dose, a 5 mg vial provides 20 doses — about 2.9 weeks of daily supply. The vial duration calculator runs the math for any combination of vial size, dose, and frequency.
Does BPC-157 need to be refrigerated?
Lyophilized powder is typically stored refrigerated, and the reconstituted vial is kept refrigerated and used within several weeks. Writing the reconstitution date on the vial helps prevent using a long-opened vial past its useful life.
Should every injection site be recorded?
Recording the site is what surfaces rotation patterns weeks later. Peptide Pilot includes a site picker for exactly this reason — clicking a body diagram is faster than typing the location and produces cleaner trend data.
What is the structural origin of BPC-157?
BPC-157 is a peptide fragment with the 15-amino-acid sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is not a naturally occurring peptide on its own, but rather a synthetic copy of a sequence isolated from a larger protein called Body Protection Compound found in human gastric juice. Its unusual structure, particularly its proline-rich core, is studied for its potential role in the peptide's high stability.
Why is the administration route a critical variable to track for BPC-157?
Unlike many peptides that are almost exclusively studied via injection, BPC-157 has been explored in animal research through both subcutaneous and oral administration routes. Because the delivery method is a fundamental variable that influences how a substance is absorbed and distributed, it is a critical data point to log. Tracking whether a dose was administered orally or via injection is essential for maintaining an accurate and auditable personal record over time.
How does tracking a BPC-157 and TB-500 'stack' differ from tracking them individually?
Tracking these two peptides in a stack requires managing two distinct schedules within a single log. Research protocols for BPC-157 often involve a daily administration cadence. In contrast, TB-500 (or its active fragment) is typically documented with a less frequent schedule, such as twice-weekly. A proper log must record each administration event separately, noting the specific peptide, dose, and date to accurately observe any patterns or outcomes without conflating the effects of two different protocols.

Related on Peptide Pilot

Save your BPC-157 vial in the app

Download on the App Store
Get the App